A groundbreaking clinical trial has found that engaging in a structured exercise program shortly after completing adjuvant chemotherapy for colon cancer significantly prolongs disease-free survival and shows evidence of improving overall survival in patients. The study, known as the CHALLENGE trial, emphasizes the vital role of physical activity in long-term cancer recovery.
Funded by the Canadian Cancer Society and various research partners, the CHALLENGE trial (ClinicalTrials.gov number, NCT00819208) focused on stage II and III colon cancer survivors who had completed chemotherapy. Participants were assigned a three-year structured physical activity regimen that incorporated aerobic and resistance training components, supervised and tailored to the individual’s fitness level and recovery status.
Results from the multi-year study revealed a statistically significant improvement in disease-free survival among participants who adhered to the exercise protocol compared to those who received usual care. While overall survival improvement was not statistically definitive, trends suggested a potential long-term benefit.
Researchers noted that the intervention not only contributed to enhanced physical health but also may play a preventative role in cancer recurrence. This underscores the increasingly recognized importance of lifestyle interventions as complementary strategies in cancer survivorship care.
The findings are likely to influence future guidelines on post-treatment recommendations for colon cancer patients, advocating physical activity as a critical element of recovery and long-term health.
These results add to a growing body of evidence that supports the integration of exercise into cancer treatment programs and survivorship planning, offering hope and tangible benefits to millions of cancer survivors worldwide.
Source: https:// – Courtesy of the original publisher.
